Ingredion to Buy Tate & Lyle for £2.7bn at 59% Premium
UL•Tate & Lyle has agreed to a £2.7bn takeover by Ingredion at 615p per share, representing a 59% premium to its closing price on May 13. The sweeteners maker has endured a share price slump after issuing multiple profit warnings due to weaker Splenda demand and invested £1.4bn in CP Kelco to bolster its reduced-sugar ingredients portfolio.
1. Deal Terms and Valuation
Tate & Lyle's board unanimously approved Ingredion's £2.7bn takeover at 595p per share plus dividends, raising the total to 615p per share, a 59% premium to its closing price on May 13. The deal secures a significant uplift for shareholders after recent share underperformance.
2. Operational Headwinds
The company has faced a notable share price slump after issuing multiple profit warnings due to weaker consumer demand for its Splenda sweetener and broader economic uncertainty in key markets. These challenges weighed on revenues and led to cost-cutting measures.
3. Strategic Expansion
In a bid to diversify beyond sweeteners, Tate & Lyle invested £1.4bn last year to acquire CP Kelco, expanding its portfolio of texture and mouthfeel ingredients used in reduced-sugar and reduced-fat food products. Management views this segment as a growth driver amid shifting consumer preferences.
4. Acquisition Context
This takeover is the latest in a series of US acquisitions of British food and ingredients businesses, following high-profile deals such as Unilever’s sale of Marmite brands. The transaction underscores ongoing consolidation in the global food ingredients sector and the appeal of UK targets to overseas buyers.
